Back to Search
Start Over
Azithromycin to Prevent Pertussis in Household Contacts, Catalonia and Navarre, Spain, 2012-2013
- Source :
- EMERGING INFECTIOUS DISEASES, r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau, instname, Emerging Infectious Diseases, r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu, Emerging Infectious Diseases, Vol 26, Iss 11, Pp 2678-2684 (2020)
- Publication Year :
- 2020
- Publisher :
- CENTERS DISEASE CONTROL & PREVENTION, 2020.
-
Abstract
- We retrospectively assessed the effectiveness of azithromycin in preventing transmission of pertussis to a patient's household contacts. We also considered the duration between symptom onset in the primary patient and azithromycin administration. We categorized contacts into 4 groups: those treated within 21 days after illness onset in the primary patient. We studied 476 primary index patients and their 1,975 household contacts, of whom 4.5% were later identified as having pertussis. When contacts started chemoprophylaxis within 14 days after primary patient's symptom onset was less effective. We recommend that contacts of persons with pertussis begin chemoprophylaxis within
- Subjects :
- Spain
Male
Bordetella pertussis
Pediatrics
Whooping Cough
Epidemiology
lcsh:Medicine
Azithromycin
0302 clinical medicine
prevention
Azithromycin to Prevent Pertussis in Household Contacts, Catalonia and Navarre, Spain, 2012–2013
Medicine
030212 general & internal medicine
Child
bacteria
antimicrobials
biology
Transmission (medicine)
pertussis
Infectious Diseases
household contacts
Child, Preschool
Chemoprophylaxis
Female
medicine.drug
Adult
Microbiology (medical)
medicine.medical_specialty
Adolescent
030231 tropical medicine
effectiveness
Therapeutics
lcsh:Infectious and parasitic diseases
Young Adult
respiratory infections
03 medical and health sciences
Tos ferina
Humans
lcsh:RC109-216
Symptom onset
Retrospective Studies
Whooping cough
business.industry
Research
lcsh:R
chemoprophylaxis
Infant
Antibiotic Prophylaxis
Terapèutica
biology.organism_classification
azithromycin
business
Subjects
Details
- ISSN :
- 10806040
- Database :
- OpenAIRE
- Journal :
- EMERGING INFECTIOUS DISEASES, r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau, instname, Emerging Infectious Diseases, r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu, Emerging Infectious Diseases, Vol 26, Iss 11, Pp 2678-2684 (2020)
- Accession number :
- edsair.doi.dedup.....2baf0a53d0dd84999aa7716ade6ac332